Federal judge blocks enforcement of Kennedy’s vaccine policies

Why It Matters

A federal court decision has temporarily halted enforcement of vaccine policies implemented by Health Secretary Robert F. Kennedy Jr., creating immediate uncertainty around national immunization guidelines. The ruling directly affects which vaccines insurance companies cover, how accessible immunizations are to the public, and which recommendations doctors follow when treating patients across the United States. The decision centers on whether the Trump administration properly reconstituted a key CDC advisory panel, raising constitutional questions about how federal health agencies can restructure decision-making bodies that influence medical practice nationwide.

What Happened

U.S. District Court Judge Brian E. Murphy in Massachusetts issued an order blocking enforcement of several vaccine policies approved by the Advisory Committee on Immunization Practices (ACIP), a CDC panel responsible for setting national vaccination guidelines. The ruling came in response to a lawsuit filed by the American Academy of Pediatrics in July 2025.

Kennedy dismissed all 17 members of the ACIP committee in June 2025 and replaced them with new appointees, several of whom have publicly expressed skepticism about vaccine safety and efficacy. The new committee subsequently voted to overturn the longstanding recommendation that all newborn babies receive hepatitis B vaccination, emphasized potential risks associated with COVID-19 vaccines, and moved to ban commonly used vaccine preservatives including thimerosal.

Judge Murphy determined that the Trump administration violated the Administrative Procedure Act by failing to appoint qualified, nonpartisan experts as required by the committee’s charter. The judge’s order temporarily halts enforcement of all recommendations voted on by the reconstituted panel and prevents 13 of the panel’s 15 members from participating in upcoming meetings, effectively paralyzing the committee’s operations.

The ruling prevents implementation of policies that would reshape decades of vaccination practice. The hepatitis B vaccine recommendation, established in 1991, has been credited with reducing hepatitis B infection rates among infants by over 95 percent. The decision to remove it from standard newborn protocols would have affected vaccination schedules across pediatric practices nationwide.

By The Numbers

• 17 members dismissed and replaced by Kennedy in June 2025
• 13 of 15 new committee members prevented from participating by court order
• Over 30 years of hepatitis B vaccination recommendations potentially affected
• 95 percent reduction in infant hepatitis B infection rates since the 1991 recommendation was implemented
• Lawsuit filed by American Academy of Pediatrics in July 2025, approximately 11 months before the ruling

Zoom Out

The ACIP committee serves as the foundation for vaccine policy across multiple federal programs and influences private insurance coverage decisions. Recommendations from the panel determine eligibility for vaccines under the Vaccine Injury Compensation Program and guide which immunizations Medicaid and Medicare will cover.

Kennedy’s restructuring of the committee represents one of the most significant challenges to the CDC’s independence in recent decades. Similar conflicts over scientific advisory boards have emerged in other federal agencies during the Trump administration, including debates over the composition of the Environmental Protection Agency’s scientific advisory committees and the composition of panels guiding pharmaceutical regulation.

The decision also reflects broader national litigation patterns around vaccine policy. Multiple states have faced court challenges regarding immunization mandates and requirements, though most have centered on individual mandate authority rather than the composition of federal advisory bodies. This case uniquely addresses whether executive branch officials can unilaterally reconstitute scientific committees without following statutory procedures.

What’s Next

The Trump administration is expected to appeal Judge Murphy’s decision to the U.S. Court of Appeals for the First Circuit. The appeals process typically takes 12 to 18 months, during which the temporary halt on enforcement and committee participation remains in effect.

The ACIP committee’s inability to function normally will likely delay updates to vaccination recommendations for diseases including influenza, pneumococcal infections, and emerging pathogens. The CDC may issue interim guidance without ACIP approval, though such recommendations carry less authority than official committee-endorsed policies.

The American Academy of Pediatrics indicated willingness to negotiate with federal health agencies rather than continue litigation, suggesting potential settlement discussions could occur during the appeals process. Any resolution would likely require either reinstatement of previous committee members or demonstration that new appointees meet statutory qualifications for scientific expertise and lack conflicts of interest.